|
1
|
Tong Y, Tar M, Melman A and Davies K: The
opiorphin gene (ProL1) and its homologues function in erectile
physiology. BJU Int. 102:736–740. 2008. View Article : Google Scholar
|
|
2
|
Wisner A, Dufour E, Messaoudi M, Nejdi A,
Marcel A, Ungeheuer MN and Rougeot C: Human opiorphin, a natural
antinociceptive modulator of opioid-dependent pathways. Proc Natl
Acad Sci USA. 103:17979–17984. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mizerska-Dudka M and Kandefer-Szerszeń M:
Opioids, neutral endopeptidase, its inhibitors and cancer: Is there
a relationship among them? Arch Immunol Ther Exp (Warsz).
63:197–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maguer-Satta V, Besançon R and
Bachelard-Cascales E: Concise review: Neutral endopeptidase (CD10):
A multifaceted environment actor in stem cells, physiological
mechanisms, and cancer. Stem Cells. 29:389–396. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen L, Lin YL, Peng G and Li F:
Structural basis for multifunctional roles of mammalian
aminopeptidase N. Proc Natl Acad Sci USA. 109:17966–17971. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sørensen KD, Abildgaard MO, Haldrup C,
Ulhøi BP, Kristensen H, Strand S, Parker C, Høyer S, Borre M and
Ørntoft TF: Prognostic significance of aberrantly silenced ANPEP
expression in prostate cancer. Br J Cancer. 108:420–428. 2013.
View Article : Google Scholar
|
|
7
|
Piattelli A, Fioroni M, Iezzi G, Perrotti
V, Stellini E, Piattelli M and Rubini C: CD10 expression in stromal
cells of oral cavity squamous cell carcinoma: A clinic and
pathologic correlation. Oral Dis. 12:301–304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Erhuma M, Köbel M, Mustafa T, Wulfänger J,
Dralle H, Hoang-Vu C, Langner J, Seliger B and Kehlen A: Expression
of neutral endopeptidase (NEP/CD10) on pancreatic tumor cell lines,
pancreatitis and pancreatic tumor tissues. Int J Cancer.
120:2393–2400. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kawamura J, Shimada Y, Kitaichi H, Komoto
I, Hashimoto Y, Kaganoi J, Miyake M, Yamasaki S, Kondo K and
Imamura M: Clinicopathological significance of aminopeptidase
N/CD13 expression in human gastric carcinoma.
Hepatogastroenterology. 54:36–40. 2007.PubMed/NCBI
|
|
10
|
Leemans CR, Snijders PJF and Brakenhoff
RH: The molecular landscape of head and neck cancer. Nat Rev
Cancer. 18:269–282. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Higgins GS, O'Cathail SM, Muschel RJ and
McKenna WG: Drug radiotherapy combinations: Review of previous
failures and reasons for future optimism. Cancer Treat Rev.
41:105–113. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Castilho RM, Squarize CH and Almeida LO:
Epigenetic modifications and head and neck cancer: Implications for
tumor progression and resistance to therapy. Int J Mol Sci.
18:15062017. View Article : Google Scholar
|
|
13
|
Caudell JJ, Torres-Roca JF, Gillies RJ,
Enderling H, Kim S, Rishi A, Moros EG and Harrison LB: The future
of personalised radiotherapy for head and neck cancer. Lancet
Oncol. 18:e266–e273. 2017. View Article : Google Scholar
|
|
14
|
Koffler J, Holzinger D, Sanhueza GA,
Flechtenmacher C, Zaoui K, Lahrmann B, Grabe N, Plinkert PK and
Hess J: Submaxillary gland androgen-regulated protein 3A expression
is an unfavorable risk factor for the survival of oropharyngeal
squamous cell carcinoma patients after surgery. Eur Arch
Otorhinolaryngol. 270:1493–1500. 2013. View Article : Google Scholar
|
|
15
|
Grünow J, Rong C, Hischmann J, Zaoui K,
Flechtenmacher C, Weber KJ, Plinkert P and Hess J: Regulation of
submaxillary gland androgen-regulated protein 3A via estrogen
receptor 2 in radioresistant head and neck squamous cell carcinoma
cells. J Exp Clin Cancer Res. 36:252017. View Article : Google Scholar
|
|
16
|
Lang Z, Wu Y, Pan X, Qu G and Zhang T:
Study of differential gene expression between invasive
multifocal/multicentric and unifocal breast cancer. J BUON.
23:134–142. 2018.PubMed/NCBI
|
|
17
|
Jiang L, Ji N, Zhou Y, Li J, Liu X, Wang
Z, Chen Q and Zeng X: CAL 27 is an oral adenosquamous carcinoma
cell line. Oral Oncol. 45:e204–e207. 2009. View Article : Google Scholar
|
|
18
|
Sravya T, Rao GV, Kumar MP and
Sudheerkanth K: Oral adenosquamous carcinoma: Report of a rare
entity with a special insight on its histochemistry. J Oral
Maxillofac Pathol. 20:5482016. View Article : Google Scholar
|
|
19
|
Holzinger D, Schmitt M, Dyckhoff G, Benner
A, Pawlita M and Bosch FX: Viral RNA patterns and high viral load
reliably define oropharynx carcinomas with active HPV16
involvement. Cancer Res. 72:4993–5003. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Karsai S, Abel U, Roesch-Ely M, Affolter
A, Hofele C, Joos S, Plinkert PK and Bosch FX: Comparison of
p16(INK4a) expression with p53 alterations in head and neck cancer
by tissue microarray analysis. J Pathol. 211:314–322. 2007.
View Article : Google Scholar
|
|
21
|
Nasser W, Flechtenmacher C, Holzinger D,
Hofele C and Bosch FX: Aberrant expression of p53, p16INK4a and
Ki-67 as basic biomarker for malignant progression of oral
leukoplakias. J Oral Pathol Med. 40:629–635. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Horn D, Freudlsperger C, Holzinger D,
Kunzmann K, Plinkert P, Dyckhoff G, Hoffmann J, Freier K and Hess
J: Upregulation of pAKT(Ser473) expression in progression of
HPV-positive oropharyngeal squamous cell carcinoma. Head Neck.
39:2397–2405. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Freudlsperger C, Horn D, Weißfuß S,
Weichert W, Weber KJ, Saure D, Sharma S, Dyckhoff G, Grabe N,
Plinkert P, et al: Phosphorylation of AKT(Ser473) serves as an
independent prognostic marker for radiosensitivity in advanced head
and neck squamous cell carcinoma. Int J Cancer. 136:2775–2785.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grégoire V, Langendijk JA and Nuyts S:
Advances in radiotherapy for head and neck cancer. J Clin Oncol.
33:3277–3284. 2015. View Article : Google Scholar
|
|
25
|
Barton MB, Jacob S, Shafiq J, Wong K,
Thompson SR, Hanna TP and Delaney GP: Estimating the demand for
radiotherapy from the evidence: A review of changes from 2003 to
2012. Radiother Oncol. 112:140–144. 2014. View Article : Google Scholar
|
|
26
|
Acuña Sanhueza GA, Faller L, George B,
Koffler J, Misetic V, Flechtenmacher C, Dyckhoff G, Plinkert PP,
Angel P, Simon C and Hess J: Opposing function of MYBBP1A in
proliferation and migration of head and neck squamous cell
carcinoma cells. BMC Cancer. 12:722012. View Article : Google Scholar
|
|
27
|
Fu S, Tar MT, Melman A and Davies KP:
Opiorphin is a master regulator of the hypoxic response in corporal
smooth muscle cells. FASEB J. 28:3633–3644. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Javelot H, Messaoudi M, Garnier S and
Rougeot C: Human opiorphin is a naturally occurring antidepressant
acting selectively on enkephalin-dependent delta-opioid pathways. J
Physiol Pharmacol. 61:355–362. 2010.
|
|
29
|
Tian XZ, Chen J, Xiong W, He T and Chen Q:
Effects and underlying mechanisms of human opiorphin on colonic
motility and nociception in mice. Peptides. 30:1348–1354. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mukherjee A, Park A, Wang L and Davies KP:
Role of opiorphin genes in prostate cancer growth and progression.
Future Oncol. 17:2209–2223. 2021. View Article : Google Scholar
|
|
31
|
Carl-McGrath S, Lendeckel U, Ebert M and
Röcken C: Ectopeptidases in tumour biology: A review. Histol
Histopathol. 21:1339–1353. 2006.
|
|
32
|
Fujita S, Yamamoto S, Akasu T, Moriya Y,
Taniguchi H and Shimoda T: Quantification of CD10 mRNA in
colorectal cancer and relationship between mRNA expression and
liver metastasis. Anticancer Res. 27:3307–3311. 2007.PubMed/NCBI
|
|
33
|
Luo Y, Fujii K, Ohmori H, Sasahira T,
Moriwaka Y, Isobe M and Kuniyasu H: Antisense phosphorothioate
oligodeoxynucleic acid for CD10 suppresses liver metastasis of
colorectal cancer. Pathobiology. 76:267–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kuniyasu H, Luo Y, Fujii K, Sasahira T,
Moriwaka Y, Tatsumoto N, Sasaki T, Yamashita Y and Ohmori H: CD10
enhances metastasis of colorectal cancer by abrogating the
anti-tumoural effect of methionine-enkephalin in the liver. Gut.
59:348–356. 2010. View Article : Google Scholar
|
|
35
|
Chua RG, Calenda G, Zhang X, Siragusa J,
Tong Y, Tar M, Aydin M, DiSanto ME, Melman A and Davies KP:
Testosterone regulates erectile function and Vcsa1 expression in
the corpora of rats. Mol Cell Endocrinol. 303:67–73. 2009.
View Article : Google Scholar
|
|
36
|
Señorale-Pose M, Jacqueson A, Rougeon F
and Rosinski-Chupin I: Acinar cells are target cells for androgens
in mouse submandibular glands. J Histochem Cytochem. 46:669–678.
1998. View Article : Google Scholar
|
|
37
|
Derer A, Spiljar M, Bäumler M, Hecht M,
Fietkau R, Frey B and Gaipl US: Chemoradiation increases PD-L1
expression in certain melanoma and glioblastoma cells. Front
Immunol. 7:6102016. View Article : Google Scholar
|
|
38
|
Guglas K, Kolenda T, Teresiak A,
Kopczyńska M, Łasińska I, Mackiewicz J, Mackiewicz A and Lamperska
K: lncRNA expression after irradiation and chemoexposure of HNSCC
cell lines. Noncoding RNA. 4:332018.
|
|
39
|
Ricco N, Flor A, Wolfgeher D, Efimova EV,
Ramamurthy A, Appelbe OK, Brinkman J, Truman AW, Spiotto MT and
Kron SJ: Mevalonate pathway activity as a determinant of radiation
sensitivity in head and neck cancer. Mol Oncol. 13:1927–1943. 2019.
View Article : Google Scholar
|
|
40
|
Todorovic V, Prevc A, Zakelj MN, Savarin
M, Brozic A, Groselj B, Strojan P, Cemazar M and Sersa G:
Mechanisms of different response to ionizing irradiation in
isogenic head and neck cancer cell lines. Radiat Oncol. 14:2142019.
View Article : Google Scholar
|
|
41
|
Wu Q, Cao R, Chen J and Xie X: Screening
and identification of biomarkers associated with
clinicopathological parameters and prognosis in oral squamous cell
carcinoma. Exp Ther Med. 18:3579–3587. 2019.PubMed/NCBI
|
